However, symptoms may temporarily recur when the dose is increased, as Ozempic is gradually titrated upwards to reach the therapeutic target
Patients routinely fly in to be evaluated by COEM, as we serve patients nationally and internationally
These medications mimic a hormone released from your digestive tract called glucagon-like peptide (GLP-1), which helps lower blood sugar and promotes a feeling of fullness
PBM claims data for CVS Health Book of Business, Commercial Clients (Health Plan + Employer), April 15 November 30, 2023
Serious injuries and symptoms discussed in Wegovy and GLP-1 litigation may include: Gastroparesis or delayed gastric emptying Stomach paralysis symptoms, including nausea, vomiting, bloating, abdominal pain, early fullness, and difficulty keeping food down Ileus or intestinal blockage Bowel obstruction or pseudo-obstruction Persistent vomiting and dehydration Malnutrition or inability to tolerate normal food intake Severe abdominal pain requiring emergency care or hospitalization Pancreatitis, which has been reported as a risk signal in GLP-1 research NAION-related vision loss, which should be evaluated separately from gastrointestinal injury claims These allegations do not mean every patient who used Wegovy has a claim
PubMed Ozkaya DY, Haymana C, Demirci I, et al